Latest filing published 04 Nov 2025 for NovoCure Ltd, €8,331.
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
All filings by Michal Nath Puri on record concern Novocure Ltd. In total, 14 filings cover trades dated from 31 October 2023 to 4 March 2026.
Sales make up the whole of the open-market record (7 sales, €94k). Outside the open market, there are 7 share grants. Since January 2026: no purchases and 2 sales on the market.
Most recently, on 5 March 2026, the filings show an open-market sale worth €13k in Novocure Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations